Tobacco Control

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
[Advanced]

The most recent version of this article was published on 1 June 2008

Tob Control. Published Online First: 4 April 2008. doi:10.1136/tc.2007.022582
Copyright © 2008 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
tc.2007.022582v1
17/3/198    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Kenfield, S. A.
Right arrow Articles by Colditz, G. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kenfield, S. A.
Right arrow Articles by Colditz, G. A.

RESEARCH PAPERS

Comparison of Aspects of Smoking Among Four Histologic Types of Lung Cancer

Stacey A. Kenfield1, Esther K. Wei, Meir J. Stampfer2, Bernard A. Rosner2, Graham A. Colditz3

1 Harvard School of Public Health, Brigham and Women's Hospital and Harvard Medical School, United States;
2 Brigham and Women's Hospital, Harvard Medical School, and Harvard School of Public Health, United States;
3 Washington University School of Medicine, United States

To whom correspondence should be addressed. E-mail: skenfiel{at}hsph.harvard.edu


ABSTRACT
The magnitude of the link between cigarette smoking and lung cancer may vary by histologic type. We used polytomous logistic regression to evaluate whether aspects of smoking have different effects across four histologic types in the Nurses’ Health Study. From 1976 through 2002, we identified 1,062 cases of lung cancer: squamous cell (n=201), small cell (n=236), adenocarcinoma (n=543), and large cell carcinoma (n=82), among 65,560 current or former smokers. Risk reduction after quitting ranged from an 8% reduction (relative risk (RR): 0.92, 95% confidence interval (CI): 0.91, 0.94) to a 17% reduction (RR: 0.83, 95% CI: 0.80, 0.86) per year for adenocarcinoma and small cell carcinoma, respectively, with a 9% reduction observed for large cell carcinoma and an 11% reduction observed for squamous cell carcinoma. The association of age at smoking initiation and former cigarette smoking was similar across types, while the association of smoking duration differed. The risk of adenocarcinoma increased by 6% per year of smoking, compared to 7% for large cell, 10% for squamous cell, and 12% for small cell. The 6% difference between adenocarcinoma and small cell carcinoma is equivalent to a 3.2 to 9.7-fold increase in risk for 20 years of smoking. The effects of the number of cigarettes smoked per day and years since quitting smoking are different across the major types of lung cancer, which are fully appreciated at long durations of smoking and smoking cessation. Smoking prevention and cessation should continue to be the focus of public health efforts to reduce lung cancer incidence and mortality.








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 by the BMJ Publishing Group Ltd.